VTGN — Vistagen Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapNeutral

Annual balance sheet for Vistagen Therapeutics, fiscal year end - March 31st, USD millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	1.36	103	68.1	16.6	119
Net Total Receivables	0	0.041	0.338	0.275	—
Prepaid Expenses
Total Other Current Assets
Total Current Assets	1.58	104	71	17.5	121
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	3.79	3.59	3.08	2.77	2.25
Other Long Term Assets
Total Assets	5.77	108	74.6	21.1	124
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	2.77	4.19	5.77	4.57	5.12
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	11.5	16.3	9.93	9.01	9.37
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Total Equity	-5.73	92	64.7	12.1	114
Total Liabilities & Shareholders' Equity	5.77	108	74.6	21.1	124
Total Common Shares Outstanding
Total Preferred Shares Outstanding